1,4-dihydropyridine has been researched along with Peritonitis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagasaki, Y; Ando, R; Echizen, H; Fukui, H; Hayano, K; Horigome, I; Kamekawa, T; Kawaguchi, Y; Koyama, T; Kubo, H; Kugiyama, A; Kuriyama, S; Miwa, S; Nakamura, Y; Nakayama, M; Nishitani, H; Okamoto, R; Saima, S; Shirai, D; Tomura, S; Tsubakihara, Y; Yasui, A; Yokoyama, K; Yoshimoto, K | 1 |
1 other study(ies) available for 1,4-dihydropyridine and Peritonitis
| Article | Year |
|---|---|
Dihydropyridine type calcium channel blocker-induced turbid dialysate in patients undergoing peritoneal dialysis.
Topics: Calcium Channel Blockers; Chylous Ascites; Data Collection; Diagnosis, Differential; Dialysis Solutions; Dihydropyridines; Female; Humans; Japan; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1998 |